Omeros (OMER) Cash & Equivalents (2010 - 2026)

Omeros' (OMER) quarterly Cash & Equivalents came in at $1.9 million in Q1 2026, down 55.27% year-on-year from $4.3 million in Q1 2025, and down 80.27% quarter-over-quarter from $9.7 million in Q4 2025.

Omeros (OMER) Cash & Equivalents (2010 - 2026) Analysis & Trends

Omeros has disclosed Cash & Equivalents across 17 years of filings, most recently posting $1.9 million for Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $1.9 million, down 55.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 55.27% YoY), and the FY2025 annual result was $9.7 million, up 184.12% from the prior year.
  • Cash & Equivalents came in at $1.9 million for Q1 2026 at Omeros, down from $9.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $230.3 million in Q1 2024 to a low of $1.9 million in Q1 2026.
  • The 5-year median for Cash & Equivalents is $11.0 million (2022), against an average of $58.8 million.
  • Across the five-year window, Cash & Equivalents surged 5960.53% in 2024 and sank 98.15% in 2025, its largest moves.
  • Omeros' Cash & Equivalents stood at $11.0 million in 2022, then slumped by 35.46% to $7.1 million in 2023, then sank by 52.15% to $3.4 million in 2024, then surged by 184.12% to $9.7 million in 2025, then tumbled by 80.27% to $1.9 million in 2026.
  • The last three Cash & Equivalents figures came in at $1.9 million (Q1 2026), $9.7 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn 1.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.91 Mn
Dec 31, 2025 9.66 Mn
Sep 30, 2025 2.40 Mn
Jun 30, 2025 28.70 Mn
Mar 31, 2025 4.26 Mn
Dec 31, 2024 3.40 Mn
Sep 30, 2024 123.20 Mn
Jun 30, 2024 158.90 Mn
Mar 31, 2024 230.30 Mn
Dec 31, 2023 7.11 Mn
Sep 30, 2023 30.64 Mn
Jun 30, 2023 6.60 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 11.01 Mn
Sep 30, 2022 221.00 Mn
Jun 30, 2022 14.10 Mn
Mar 31, 2022 142.20 Mn
Dec 31, 2021 100.81 Mn
Sep 30, 2021 7.42 Mn
Jun 30, 2021 12.70 Mn